"Substituted 4-Benzyl And 4-Benzoyl Piperidine Derivates" in Patent Application Approval Process (USPTO 20240166625).

A patent application for "Substituted 4-Benzyl And 4-Benzoyl Piperidine Derivates" has been made available online. The application discusses the role of fatty acid synthase (FASN) in various diseases, including cancer, metabolic disorders, and viral infections. The inventors propose compounds that target FASN as potential treatments for these conditions. The application also mentions the potential use of FASN inhibitors in the treatment of obesity and the modulation of immune responses. [Extracted from the article]

Copyright of Drug Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)